Imagen de Portada

MAP3K6 functions in compensatory feedback signaling during clinical interventions featuring use of the VEGF-A inhibitor bevacizumab.

Fuente: Zenodo

Guardado en:

Detalles Bibliográficos
Autor principal:	Mamoor, Shahan
Formato:	Recurso digital
Publicado:	Zenodo 2025
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: MAP2K3.
por: Mamoor, Shahan
Publicado: (2025)

Feedback activation of VEGF-A resulting from PAX8 inhibition in cancer cells.
por: Mamoor, Shahan
Publicado: (2026)

Androgen signaling has functions in lineage commitment in the human embryo.
por: Mamoor, Shahan
Publicado: (2026)

Control of TOX transcription factors by the Hippo signaling pathway.
por: Mamoor, Shahan
Publicado: (2025)

Glucocorticoid resistance features changes in general transcription factor (GTF) expression.
por: Mamoor, Shahan
Publicado: (2025)

FCGRT functions in senescence and transformation.
por: Mamoor, Shahan
Publicado: (2025)

ABCA12 functions in multi-drug resistance in human cancer.
por: Mamoor, Shahan
Publicado: (2025)

A comprehensive description of the circulating tumor cell: TM6SF1.
por: Mamoor, Shahan
Publicado: (2025)

Matrix metalloproteinases MMP1/MMP9 function in melanoma resistance.
por: Mamoor, Shahan
Publicado: (2025)

ABCG2 functions in multi-drug resistance in human cancer in metastasis to the bone.
por: Mamoor, Shahan
Publicado: (2025)

Genes that function in axon guidance are associated with disease progression in breast and lung cancer.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: GALNT6.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: HOXB6.
por: Mamoor, Shahan
Publicado: (2025)

H7N9 PA-X silences Ifi6.
por: Mamoor, Shahan
Publicado: (2026)

Haglr, a HOXD antisense growth-associated long non-coding RNA with functions in lineage commitment in the human embryo.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: PPP6R1.
por: Mamoor, Shahan
Publicado: (2025)

A comprehensive description of the circulating tumor cell: EXD3.
por: Mamoor, Shahan
Publicado: (2025)

A comprehensive description of the circulating tumor cell: Fzd4/Fzd3.
por: Mamoor, Shahan
Publicado: (2025)

Kinase targeting in Luminal A breast cancer: PIK3R1.
por: Mamoor, Shahan
Publicado: (2025)

The integral membrane protein SMIM38 is transcriptionally activated in circulating tumor cells in human breast cancer in conjunction with two SMIM38-interacting proteins of undefined function, ETDA and ETDB.
por: Mamoor, Shahan
Publicado: (2025)

Chemokine activation during cellular senescence.
por: Mamoor, Shahan
Publicado: (2024)

A retrotransposon-like gene, RTL5, is modulated during differentiation of embryonic stem cells to the trophectoderm lineage.
por: Mamoor, Shahan
Publicado: (2026)

Rip kinase expression during early development in humans.
por: Mamoor, Shahan
Publicado: (2026)

Gasdermin activation during lineage specification in the human embryo.
por: Mamoor, Shahan
Publicado: (2026)

Xist is activated during resistance in triple negative breast cancer in vitro.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: WNK3.
por: Mamoor, Shahan
Publicado: (2025)

SLX1B is active during transformation and controls relapse and resistance in human cancer.
por: Mamoor, Shahan
Publicado: (2025)

Fam234b is selectively activated during the first cell division of the human embryo.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: GPSM3.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in lung cancer for the treatment of lymph node metastasis: GRIK3.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: HMGB3.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: PIK3CD.
por: Mamoor, Shahan
Publicado: (2025)

Casz1 mobilization during TE lineage specification from the pluripotent state in embryonic stem cells.
por: Mamoor, Shahan
Publicado: (2026)

Immunoglobulin-based therapeutic targeting for treatment of metastasis to the skeletal system: C3orf52.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ENPP3.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in androgen receptor positive triple negative breast cancer (AR+ TNBC): GRK3.
por: Mamoor, Shahan
Publicado: (2025)

Kinase activation during small molecule inhibition of the receptors for the vascular endothelial growth factors VEGFR1 and VEGFR2.
por: Mamoor, Shahan
Publicado: (2025)

Clec2b and Clec11a, co-receptors for KIR2DL3 natural killer cell self discrimination complexes, are altered in expression in the cells of patients with IBD.
por: Mamoor, Shahan
Publicado: (2025)

The genes encoded at the Dxz locus, DANT2/3, are components of an Xist gene expression regulation apparatus that utilizes quantitative control of message quantity of specific genes to measure and maintain transcription, globally, within homeostatic range.
por: Mamoor, Shahan
Publicado: (2025)

A comprehensive description of the circulating tumor cell: GPRC5A.
por: Mamoor, Shahan
Publicado: (2025)